Literature DB >> 12640156

MR imaging of common and uncommon large pelvic masses.

Janio Szklaruk1, Eric P Tamm, Haesun Choi, Vithya Varavithya.   

Abstract

Magnetic resonance (MR) imaging is often used in the detection and staging of large pelvic masses. Many large masses in the female pelvis arise from the reproductive organs (eg, uterus, cervix, ovaries, fallopian tubes). In addition, these masses may arise from the gastrointestinal system, urinary system, adjacent soft tissues, peritoneum, or retroperitoneum or from metastases. The majority of large masses in the female pelvis represent such commonly encountered entities as uterine fibroid tumor, dermoid tumor, ovarian cyst, and ovarian cancer. However, uncommon pelvic masses such as mesothelioma, adenocarcinoma, carcinosarcoma, leiomyosarcoma, and desmoid tumor may also be seen. Thus, the differential diagnosis for female pelvic masses is extensive. However, the site of origin, MR imaging characteristics, and clinical history may all help narrow the differential diagnosis. Although with large tumors it may not always be possible to determine the site of origin or distinguish between various tumors at radiology, familiarity with the clinicopathologic and MR imaging features of common and uncommon pelvic masses is important for diagnosis and treatment. Copyright RSNA, 2003

Entities:  

Mesh:

Year:  2003        PMID: 12640156     DOI: 10.1148/rg.232025089

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  25 in total

1.  Determining the organ of origin of large pelvic masses in females using multidetector CT angiography and three-dimensional volume rendering CT angiography.

Authors:  YangKang Li; Yu Zheng; JunWei Chen; XueYin Chen; JianBang Lin; AiQun Cai; XiuGuo Zhou
Journal:  Eur Radiol       Date:  2014-11-02       Impact factor: 5.315

2.  Skeletal muscle metastasis from uterine leiomyosarcoma.

Authors:  J M O'Brien; D D Brennan; D H Taylor; D P Holloway; B Hurson; J C O'Keane; S J Eustace
Journal:  Skeletal Radiol       Date:  2004-05-04       Impact factor: 2.199

Review 3.  Uterine sarcomas: clinical presentation and MRI features.

Authors:  Pedro Santos; Teresa Margarida Cunha
Journal:  Diagn Interv Radiol       Date:  2015 Jan-Feb       Impact factor: 2.630

Review 4.  Multimodality imaging review of complex pelvic lesions in female pelvis.

Authors:  Anuradha Chandramohan; Tameem Ahmed Bhat; Reetu John; Betty Simon
Journal:  Br J Radiol       Date:  2020-09-04       Impact factor: 3.039

5.  Young-onset peri-anorectal leiomyomatosis: report of a case.

Authors:  Masahide Toshima; Koh Miura; Kazuyuki Ishida; Takayuki Mizoi; Takeshi Naitoh; Hitoshi Ogawa; Shinobu Ohnuma; Hiroyuki Sasaki; Kazuhiro Watanabe; Sho Haneda; Tomohiko Sase; Taiki Kajiwara; Yoshifumi Matsuda; Chikashi Shibata; Iwao Sasaki
Journal:  Surg Today       Date:  2012-05-19       Impact factor: 2.549

6.  Dedifferentiated liposarcoma involving the spleen and splenic hilum: a report of a case with a rare growth pattern.

Authors:  Gen Nishikawa; Sachiko Minamiguchi; Hiroaki Hata; Satoshi Ogiso; Takashi Yamaguchi; Tethushi Otani; Iwao Ikai
Journal:  Int Surg       Date:  2015-01

Review 7.  Pelvic incidentalomas.

Authors:  R M Gore; G M Newmark; K H Thakrar; U K Mehta; J W Berlin
Journal:  Cancer Imaging       Date:  2010-10-04       Impact factor: 3.909

8.  Huge uterine leiomyoma with adenomyotic cysts mimicking uterine sarcoma on MR imaging.

Authors:  Tsuneo Yamashiro; Masaki Gibo; Takashi Utsunomiya; Sadayuki Murayama
Journal:  Radiat Med       Date:  2007-04-27

9.  Pelvic Mass Lesions in Females: Tissue Characterization Capability of MRI.

Authors:  Pramod Ramchand Shaha; Rahul Khetawat; Kulamani Sahoo; Ashish Garg; Mohd Abbas Ilyas; Gaurav Khairnar; Sahil Garg; Shree Hari Budgemwar
Journal:  J Clin Diagn Res       Date:  2017-07-01

10.  MR imaging features of peritoneal adenomatoid mesothelioma: a case report.

Authors:  Cynthia Maria Coelho Lins; Jorge Elias; Adilson Ferreira Cunha; Valdair Francisco Muglia; Carlos Ribeiro Monteiro; Fábio V Valeri; Omar Feres
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.